Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Cancer Profiling Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... neurological disorders and fibromyalgia among others. Sedentary lifestyles and rising chronic diseases can increase the prevalence of chronic pain globally. It negatively impacts quality of life by limiting mobility and daily functioning. Global chronic pain ... Read More
-
Genomics In Cancer Care Global Market Report 2025 Including: 1) By Product Type: Instruments; Consumables; Services 2) By Technology: PCR (Polymerase Chain Reaction); MicroArrays; Genome Sequencing 3) By Application: Diagnostics; Personalized Medicine; Drug Discovery And Development; Research 4) By End-User: Hospitals; Government Institutes; Research Facilities Covering: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V.
... cancer care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Global Thymus Cancer Market - 2023-2030
... expected to exhibit a CAGR of 5.5% during the forecast period (2024-2031). The key players are adopting strategies such as partnerships, mergers, acquisitions, novel product launches and enhanced focus on R&D and regional expansion to ... Read More
-
Global Glioblastoma(GBM) Treatment Market - 2024-2031
... nerve cells. Glioblastoma can occur at any age but tends to occur more often in older adults. Treatments include radiation, chemotherapy and surgery. North America region accounted for the largest market share. Competitive rivalry intensifies ... Read More
-
Global Cancer Tumor Profiling Market - 2024 - 2031
... is a laboratory test to check for gene mutations or other alterations that make up the tumor biology and underlie the cancer growth. This information can help physicians build a personalized treatment plan based on ... Read More
-
Global Circulating Tumor Cells (CTC) Market 2024 - 2031
... 2024-2031. Circulating tumor cells (CTCs) are tumor cells that shed from the primary tumor and intravasate into the peripheral blood circulation system responsible for metastasis. Sensitive detection of CTCs from clinical samples can serve as ... Read More
-
Global Difficult-to-Express Proteins Market - 2023-2030
... to exhibit a CAGR of 11.0% during the forecast period (2024-2031). Prokaryotic expression system research and development have increased due to the rising demand for recombinant proteins and this trend is anticipated to fuel market ... Read More
-
Global Pancreatic Cancer Market - 2024 - 2031
... to exhibit a CAGR of 11.1% during the forecast period (2024-2031). Chemotherapy medications are used to kill or stop cancer cell division. Adjuvant chemotherapy is administered after surgery to eradicate any cancer cells left over, ... Read More
-
Global Colorectal Cancer Drugs Market - 2024 - 2031
... Drugs Market is expected to exhibit a CAGR of 3.7% during the forecast period 2024-2031. The treatment of colorectal cancer typically involves a combination of surgery, radiation therapy, and chemotherapy. Besides, the treatment regimens for ... Read More
-
Global Oral Transmucosal Drugs Market- 2023-2030
... to exhibit a CAGR of 6.4% during the forecast period (2023-2030). Oraltransmucosal drug administration was an alternative route in end-of-life care and palliative care during the COVID-19 pandemic. Oral transmucosal drug delivery is the systemic ... Read More
-
Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034 Including: 1) By Type: Product; Services 2) By Cancer: Lung Cancer; Breast Cancer; Colon Cancer 3)By Sample: Blood; Urine; Saliva 4) By End User: Hospitals; Diagnostic Centers Covering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Guardant Health Inc.; Illumina Inc.; Exact Sciences Corporation
... biopsy for cancer diagnostics market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how ... Read More
-
2025 Neoplasms Global Market Size & Growth Report with Updated Analysis & Forecasts
... countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling neoplasms (tumors) (c00-d49). The survey data is combined with ... Read More
-
Global Lung Cancer Therapeutics Market 2025-2029
... cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Medical Nutrition Market, By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), By Route of Administration (Oral, Enteral, and Parenteral), By End User (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... seen significant growth over the past decade driven by the increasing prevalence of chronic diseases and growing elderly population worldwide who are more susceptible to nutritional deficiencies. Various factors, such as the rising consumer awareness ... Read More
-
Point-Of-Care Molecular Diagnostics Global Market Report 2025 Including: 1) By Product And Service: Assays And Kits; Instruments And Analyzers; Software And Services 2) By Technology: Reverse Transcription - Polymerase Chain Reaction (RT-PCR); In Situ Hybridization; Sequencing 3) By Application: Respiratory Diseases; Hospital Acquired Infections (HAIs); Cancer/Oncology; Hepatitis; Hematology 4) By End-User: Decentralized Labs; Hospitals; Home Care; Assisted Living Healthcare Facilities Covering: Abbott Laboratories; F Hoffmann-La Roche Ltd.; BioMérieux SA; Danaher Corporation; Quidel Corporation
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030
... by many rising impacts with respect to improving cases of respiratory diseases around the world. Innovative technologies in diagnosis, such as molecular diagnostics and advanced imaging solutions, have also improved the accuracy and speed of ... Read More
-
U.S. Sterile Injectables Market, By Molecule Type (Large Molecule and Small Molecule), By Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, and Others), By Therapeutic Application (Cancer, Metabolic Disorder, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal Disorders, and Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
... that are administered via various injection routes such as intravenous, intramuscular, subcutaneous, and others in their final sterile form for healing or preventing medical conditions. The rising prevalence of chronic diseases like cancer, diabetes, autoimmune ... Read More
-
Europe Liquid Biopsy Market: Focus on End User and Country - Analysis and Forecast, 2024-2033
... 2024-2033. In Europe, liquid biopsy is a new non-invasive diagnostic technique that is transforming cancer detection and surveillance. This method has the potential to early detect cancer recurrence or evaluate treatment responses, and it provides ... Read More
-
Global Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Immunotherapy Drugs Market ... Read More
-
Colposcopy
... 3.9% over the analysis period 2024-2030. Optical Colposcopy, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$580.3 Million by the end of the analysis period. Growth ... Read More
-
Sunitinib Malate
... CAGR of 9.6% over the analysis period 2024-2030. Above 99% Purity Sunitinib Malate, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$120.6 Million by the end ... Read More
-
Nano-Magnetic Devices
... CAGR of 5.4% over the analysis period 2024-2030. Nano-Magnetic Sensors, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$12.8 Billion by the end of the analysis ... Read More
-
Tumor / Cancer Markers
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 10.4% CAGR The Tumor / Cancer Markers market ... Read More
-
Chronic Myelogenous Leukemia Treatment
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.4 Billion by ... Read More
Research Assistance
